Rýchle a reverzibilné uvoľnenie pre manažment neuromuskulárnej blokády (NMB).2 – 5
Čas do 50 % a 90 % maximálneho účinku rokurónia je porovnateľný so sukcinylcholínom.2
2. Kopman et al. Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration. Anesthesiology 1999; 90(2): 425–431; 3. Tran et al. Rocuronium vs. succinylcholine for rapid sequence intubation: a Cochrane systematic review. Anaesthesia 2017; 72(6): 765–777; 4. Marsch et al. Succinylcholine versus rocuronium for rapid sequence intubation in intensive care: a prospective, randomized controlled trial. Crit Care 2011; 15(4):R199; 5. Blobner et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 2010; 27(10): 874–881.
Čas do 50 % a 90 % maximálneho účinku rokurónia je porovnateľný so sukcinylcholínom.2
2. Kopman et al. Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration. Anesthesiology 1999; 90(2): 425–431; 3. Tran et al. Rocuronium vs. succinylcholine for rapid sequence intubation: a Cochrane systematic review. Anaesthesia 2017; 72(6): 765–777; 4. Marsch et al. Succinylcholine versus rocuronium for rapid sequence intubation in intensive care: a prospective, randomized controlled trial. Crit Care 2011; 15(4):R199; 5. Blobner et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 2010; 27(10): 874–881.